Y. Nakada

发表

Design of Fexofenadine Prodrugs Based on Tissue-Specific Esterase Activity and Their Dissimilar Recognition by P-Glycoprotein.

Kayoko Ohura, T. Imai, Y. Nakada, 2015, Journal of pharmaceutical sciences.

Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides.

P. Couvreur, C. Malvy, C. Vauthier, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Absorption, Distribution, Excretion and Effects on Drug Metabolizing Enzyme Activities of a New Antiplatelet Drug, Ethyl 2-[4, 5-bis (4-methoxyphenyl) thiazol-2-yl]pyrrol-1-ylacetate (KBT-3022), after Multiple Oral Administration in Mice

M. Fujikawa, Y. Nakada, N. Awata, 1994 .

Enzyme immunoassay for 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazole, a novel 5-HT3 receptor antagonist.

M. Fujikawa, Y. Nakada, F. Teratani, 2001, Biological & pharmaceutical bulletin.

The effect of bile salts on the oral mucosal absorption of human calcitonin in rats.

Y. Nakada, N. Awata, Y. Ikuta, 1989, Journal of pharmacobio-dynamics.

The effect of additives on the oral mucosal absorption of human calcitonin in rats.

Y. Nakada, I. Sugimoto, N. Awata, 1988, Journal of pharmacobio-dynamics.

Pharmacokinetics and Biodistribution of Oligonucleotide Adsorbed onto Poly(isobutylcyanoacrylate) Nanoparticles After Intravenous Administration in Mice

P. Couvreur, E. Fattal, Y. Nakada, 2004, Pharmaceutical Research.

New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.

H. Kondo, Y. Inoue, K. Yoshino, 2002, Journal of medicinal chemistry.

Some factors affecting the vaginal absorption of human calcitonin in rats

Y. Nakada, N. Awata, Miho Miyake, 1993 .

A new cognition-enhancing agent, (R)-(-)-1-(benzo[b]thiophen-5-yl)- 2-[2-(N,N-diethylamino)ethoxy]ethanol hydrochloride. Effects on memory impairment in rats generated by cerebral embolization and basal forebrain lesions.

H. Narita, Y. Nakada, S. Ono, 1995, Biological & pharmaceutical bulletin.

Expression of Carboxylesterase Isozymes and Their Role in the Behavior of a Fexofenadine Prodrug in Rat Skin.

Kayoko Ohura, T. Imai, Y. Nakada, 2016, Journal of pharmaceutical sciences.

Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro.

K. Sakurai, T. Nakamura, Yoshiteru Takahashi, 1999, International journal of pharmaceutics.

Evaluation of long-circulating nanoparticles using biodegradable ABA triblock copolymers containing of poly(l-lactic acid) A-blocks attached to central poly(oxyethylene) B-blocks in vivo

K. Sakurai, Yoshiteru Takahashi, Y. Nakada, 1998 .

Biopharmaceutical considerations on antihistamine effects of topically administered emedastine.

M. Hashida, F. Yamashita, Y. Nakada, 2005, Journal of pharmaceutical sciences.

Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat.

Y. Nakada, Haruka Takeuchi, N. Hashimoto, 2014, Journal of pharmaceutical sciences.

Bioconversion and P-gp-mediated transport of depot fluphenazine prodrugs after intramuscular injection.

Kayoko Ohura, T. Imai, Y. Nakada, 2023, Journal of pharmaceutical sciences.

PREPARATION AND CHARACTERIZATION OF POLYLACTIDE-POLY(ETHYLENE GLYCOL)-POLYLACTIDE TRIBLOCK POLYMERS AND A PRELIMINARY IN VIVO EXAMINATION OF THE BLOOD CIRCULATION TIME FOR THE NANOPARTICLES MADE THEREFROM

K. Sakurai, Yoshiteru Takahashi, Y. Nakada, 1999 .

Application of povacoat as dispersion stabilizer of nanocrystal formulation

Y. Nakada, Haruka Takeuchi, N. Hashimoto, 2016 .